Clinical & Experimental Metastasis

, Volume 17, Issue 4, pp 323–330 | Cite as

Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells

  • Ratna Mukhopadhyay
  • Richard L. Theriault
  • Janet E. Price

Abstract

Integrins play an important role in interactions between cells and the extracellular matrix, and thus have a potential role in metastasis. Expression levels of α6, β1 and β4 integrin sub-units were measured in a panel of human breast cancer cell lines by RT/PCR, immunoprecipitation and flow cytometry. All the lines expressed α6, with the highest levels in the MDA-MB-231 and MDA-MB-435 cells. These grew the most aggressively and were metastastic in nude mice. Low levels of α6 protein were measured in breast cancer cells that were poorly tumorigenic and non-metastatic in nude mice, and there was an inverse relationship between ER and α6 expression. RT/PCR revealed that all lines expressed the 2 isoforms of α6, with the α6A isoform generally more abundant than α6B isoform. Clones of MDA-MB-435 were isolated by sterile sorting for cells with high or low α6 expression, and two variants established from metastases in nude mice were found to differ in α6 expression. When injected into nude mice, the α6-high variants produced significantly more lung metastases than the α6-low variants. β1 was abundant in all lines, while β4 was not detected in MDA-MB-134 cells, and in the MDA-MB-435 cells an alternately spliced variant of β4 was identified. Sequencing of the alternate variant revealed a novel sequence from a splicing event in the cytoplasmic tail of β4. None of the cells with this variant mRNA expressed detectable levels of β4 protein. Our results suggest that high α6 expression in human breast cancer cells is associated with tumorigenicity and metastatic potential.

breast cancer integrins metastasis progression xenograft model 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25.Google Scholar
  2. 2.
    Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425–34.Google Scholar
  3. 3.
    Dedhar S, Hannigan GE. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996; 8: 657–69.Google Scholar
  4. 4.
    Juliano R. Signal transduction by integrins and its role in the regulation of tumor growth. Cancer Metastasis Rev 1994; 13: 25–30.Google Scholar
  5. 5.
    Giancotti FG, Mainiero F. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta 1994; 1198: 47–64.Google Scholar
  6. 6.
    Chan BM, Matsuura N, Takada Y et al. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1992; 251: 1600–2.Google Scholar
  7. 7.
    Bertomeu MC, Gallo S, Lauri D et al. Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression. Clin Exp Metastasis 1993; 11: 243–50.Google Scholar
  8. 8.
    Matsuura N, Puzon-McLaughlin W, Irie A et al. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol 1996; 148: 55–61.Google Scholar
  9. 9.
    Yamamoto H, Irie A, Fukushima Y et al. Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin alpha6 subunit expression. Int J Cancer 1996; 65: 519–24.Google Scholar
  10. 10.
    Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha(6)-integrins. Cell Adhesion Commun 1993; 1: 67–81.Google Scholar
  11. 11.
    Saiki I, Murata J, Iida J et al. The inhibition of murine lung metastases by synthetic polypeptides [poly(arg-gly-asp) and poly(tyr-ile-gly-serarg)] with a core sequence of cell adhesion molecules. Br J Cancer 1988; 59: 194–7.Google Scholar
  12. 12.
    De Melker AA, Sonnenberg A. The role of the cytoplasmic domain of α6 integrin in the assembly and function of α6β1 and α6β4. Eur J Biochem 1996; 241: 254–64.Google Scholar
  13. 13.
    Hynes RO. Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol 1996; 180: 402–12.Google Scholar
  14. 14.
    Zutter MM, Mazoujian G, Santoro SA. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 1990; 137: 863–70.Google Scholar
  15. 15.
    Pignatelli M, Cardillo MR, Hanby A, Stamp GWH. Integrins and their accessory adhesion molecules in mammary carcinoma. Hum Pathol 1992; 23: 1159–66.Google Scholar
  16. 16.
    Natali PG, Nicotra MR, Botti C et al. Changes in expression of α6/β4 integrin heterodimer in primary and metastatic breast cancer. Br J Cancer 1992; 66: 318–22.Google Scholar
  17. 17.
    Koukoulis GK, Virtanen I, Korhonen M, et al. Immunohistochemical localization of integrins in normal, hyperplastic and neoplastic breast. Am J Pathol 1991; 139: 787–99.Google Scholar
  18. 18.
    Friedrichs K, Riuz P, Franke F et al. High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995; 55: 901–6.Google Scholar
  19. 19.
    Tagliabue E, Ghirelli C, Squicciarini P et al. Prognostic value of α6β4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 1998; 4: 407–10.Google Scholar
  20. 20.
    Hogervorst F, Kuikman I, Van Kessel AG, Sonnenberg A. Molecular cloning of the human α6 integrin subunit. Alternative splicing of the α6 mRNA and chromosomal localization of the α6 and β4 genes. Eur J Biochem 1991; 199: 425–33.Google Scholar
  21. 21.
    Hedman H, Alenius M, Lundgren E. Defective expression of beta 1-integrins in cells with constitutively active alpha L beta 2-integrins. Exp Cell Res 1997; 232: 270–6.Google Scholar
  22. 22.
    Tamura RN, Rozzo C, Starr L et al. Epithelial integrin α6β4: complete primary structure of α6 and variant forms of β4. J Cell Biol 1990; 111: 1593–1604.Google Scholar
  23. 23.
    Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1996; 50: 717–21.Google Scholar
  24. 24.
    Price JE. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 1996; 39: 93–102Google Scholar
  25. 25.
    Tennenbaum T, Belanger AJ, Glick AB et al. A splice variant of alpha 6 integrin is associated with malignant conversion in mouse skin tumorigenesis. Proc Natl Acad Sci USA 1995; 92: 7041–5.Google Scholar
  26. 26.
    Kemperman H, Wijnands Y, de Rijk D, Roos E. The integrin α6β4 on TA3/Ha mammary carcinoma cells is involved in adhesion to hepatocytes. Cancer Res 1993; 53: 3611–7.Google Scholar
  27. 27.
    Shaw LM, Chao C, Wewer UM, Mercurio AM. Function of the integrin α6β1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor. Cancer Res 1996; 56: 959–63.Google Scholar
  28. 28.
    Dedhar S, Saulnier R, Nagle R, Overall CM. Specific alterations in the expression of α3β1 and α6β4 integrins in highly invasive and metastatic variants of human prostatic carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin Exp Metastasis 1993; 11: 391–400.Google Scholar
  29. 29.
    Price JE, Fabra A, Zhang RD et al. Characterization of variants of a human breast cancer cell line isolated from metastases in different organs of nude mice. Int J Oncology 1994; 5: 459–67.Google Scholar
  30. 30.
    Wewer UM, Shaw LM, Albrechtsen R, Mercurio AM. The integrin α6β1 promotes the survival of metastatic human breast carcinoma cells in mice. Am J Pathol 1997; 151: 1191–8.Google Scholar
  31. 31.
    Mainiero F, Pepe A, Wary KH et al. Signal transduction by the α6β4 integrin: distinct β4 subunit sites mediate recruitment of Shc/Grb2 and association with cytoskeleton of hemidesmosomes. EMBO J 14: 4470- 81.Google Scholar
  32. 32.
    Spinardi L, Ren YL, Sanders R, Giancotti FG. The beta 4 subunit cytoplasmic domain mediates the interaction of alpha 6 beta 4 integrin with the cytoskeleton of hemidesmosomes. Mol Biol Cell 1993; 4: 871–84.Google Scholar
  33. 33.
    Pyke C, Salo S, Ralfkiaer E et al. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55: 4132–9.Google Scholar
  34. 34.
    Shaw LM, Rabinovitz I, Wang HHF et al. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell 1997; 91: 949–60.Google Scholar
  35. 35.
    Clarke AS, Lotz MM, Chao C, Mercurio AM. Activation of the p21 pathway of growth arrest and apoptosis by the beta(4) integrin cytoplasmic domain. J Biol Chem 1995; 270: 22673–6.Google Scholar
  36. 36.
    Kim SY, Bachman NJ, Nair TS et al. Beta 4 integrin transfection of UM-UC-2 (human bladder carcinoma) cells: stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact beta 4. Cancer Res 1997; 57: 38–42.Google Scholar
  37. 37.
    Clarke AS, Lotz MM, Mercurio AM. A novel structural variant of the human beta 4 integrin cDNA. Cell Adhesion Commun. 1994; 2: 1–6.Google Scholar
  38. 38.
    Strunck E, Vollmer G. Variants of integrin β4 subunit in human endometrial adenocarcinoma cells: mediators of ECM-induced differentiation? Biochem Cell Biol 1996; 74: 867–73.Google Scholar
  39. 39.
    van Valen F, Hanenberg H, Jurgens H. Expression of functional very late antigen-alpha 1,-alpha 2,-alpha 3 and-alpha 6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-gamma and tumour necrosis factor-alpha. Eur J Cancer 1994; 30A: 2119–25.Google Scholar
  40. 40.
    Kumar NM, Sigurdson SL, Sheppard D, Lwebuga-Mukasa JS. Differential modulation of integrin receptors and extracellular matrix laminin by transforming growth factor-beta 1 in rat alveolar epithelial cells. Exp Cell Res 1995; 221: 385–94.Google Scholar
  41. 41.
    Pirila L, Heino J. Altered integrin expression in rheumatoid synovial lining type B cells: in vitro cytokine regulation of alpha 1 beta 1, alpha 6 beta 1, and alpha v beta 5 integrins. J Rheumatol 1996; 23: 1691–8.Google Scholar
  42. 42.
    Lin CS, Chen Y, Huynh T, Kramer R. Identification of the human α6 integrin gene promoter. DNA Cell Biol 1997; 8: 929–37.Google Scholar
  43. 43.
    Nishida K, Kitazawa R, Mizuno K et al. Identification of regulatory elements of human α6 integrin subunit gene. Biochem Biophys Res Commun 1997; 241: 258–63.Google Scholar
  44. 44.
    Sommers CL, Byers SW, Thompson EW et al. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994; 31: 325–35.Google Scholar
  45. 45.
    Meiners S, Brinkmann V, Naundorf H, Birchmeier W. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 1998; 16: 9–20.Google Scholar
  46. 46.
    Castles CG, Klotz DM, Fuqua SAW, Hill SM. Coexpression of wildtype and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines. Br J Cancer 1995; 71: 974–80.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Ratna Mukhopadhyay
    • 1
  • Richard L. Theriault
    • 2
  • Janet E. Price
    • 1
  1. 1.Departments of Cancer BiologyUSA
  2. 2.>Medical OncologyThe University of TexasHoustonUSA

Personalised recommendations